Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen V Liu
Deepa Subramaniam
Giuseppe Giaccone

Showing results (1-10 of 498) with videos related to

Pageof 50
Sort By:
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging protein kinase inhibitors for non-small cell lung cancerStephen V Liu, Deepa Subramaniam, George C Cyriac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 5, 2014
Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directionsMauricio Burotto, Anish Thomas, Deepa Subramaniam, et al.
Discovery Medicine|May 28, 2016
Novel approaches in cancer immunotherapyDeepa S Subramaniam, Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology|May 13, 2015
Refining the treatment of NSCLC according to histological and molecular subtypesAnish Thomas, Stephen V Liu, Deepa S Subramaniam, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2014
Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesStephen V Liu, Vincent A Miller, Marinus W Lobbezoo, et al.
Seminars in Oncology|July 3, 2002
Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer 08975Giuseppe Giaccone,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancerGiuseppe Giaccone
Current Opinion in Oncology|February 24, 2005
Treatment of malignant thymomaGiuseppe Giaccone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of gefitinib in lung cancer treatmentGiuseppe Giaccone
Oncogene|October 4, 2002
Clinical impact of novel treatment strategiesGiuseppe Giaccone
Pageof 50

Showing results (1-10 of 498) with videos related to

Sort By:
Pageof 50
Expert Opinion on Emerging Drugs|December 21, 2013
Emerging protein kinase inhibitors for non-small cell lung cancerStephen V Liu, Deepa Subramaniam, George C Cyriac, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 5, 2014
Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directionsMauricio Burotto, Anish Thomas, Deepa Subramaniam, et al.
Discovery Medicine|May 28, 2016
Novel approaches in cancer immunotherapyDeepa S Subramaniam, Stephen V Liu, Giuseppe Giaccone
Nature Reviews. Clinical Oncology|May 13, 2015
Refining the treatment of NSCLC according to histological and molecular subtypesAnish Thomas, Stephen V Liu, Deepa S Subramaniam, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2014
Genomics-based early-phase clinical trials in oncology: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesStephen V Liu, Vincent A Miller, Marinus W Lobbezoo, et al.
Seminars in Oncology|July 3, 2002
Early results of a randomized phase III trial of platinum-containing doublets versus a nonplatinum doublet in the treatment of advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer 08975Giuseppe Giaccone,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancerGiuseppe Giaccone
Current Opinion in Oncology|February 24, 2005
Treatment of malignant thymomaGiuseppe Giaccone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of gefitinib in lung cancer treatmentGiuseppe Giaccone
Oncogene|October 4, 2002
Clinical impact of novel treatment strategiesGiuseppe Giaccone
Pageof 50